| |
|
HE | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
| 3. | Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial |
| |
EClinicalMedicine. 2023 Apr 4;58:101924. doi: 10.1016/j.eclinm.2023.101924.eCollection 2023 Apr.
Louise China 1, Thais Tittanegro 1, Dominic Crocombe 1, Ewan Forrest 2, Yiannis Kallis 3, Stephen D Ryder 4, Gavin Wright 5, Nick Freemantle 6, Alastair O'Brien 1 6
|
|
| |
| 4. | Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study |
| |
Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002251. Online ahead of print.
Simon Johannes Gairing 1 2, Chiara Mangini 3, Lisa Zarantonello 3, Stefania Gioia 4, Elise Jonasson Nielsen 5, Sven Danneberg 6, Maria Gabriel 7, Alena F Ehrenbauer 7, Patricia P Bloom 8, Cristina Ripoll 9 10, Philippe Sultanik 11, Peter Robert Galle 1 2, Joachim Labenz 12, Dominique Thabut 11, Alexander Zipprich 9 10, Anna S Lok 8, Karin Weissenborn 7, Jens Uwe Marquardt 6, Mette Munk Lauridsen 5, Silvia Nardelli 4, Sara Montagnese 3 13, Christian Labenz 1 2
|
|
| |
|
|
| |
|
|
| |
| 7. | Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis |
| |
J Gastrointestin Liver Dis. 2023 Apr 1;32(1):70-76. doi: 10.15403/jgld-4508.
Zohaib Ahmed 1, Mona Hassan 2, Syeda Faiza Arif 3, Muhammad Aziz 4, Umair Iqbal 5, Ahmad Nawaz 6, Umer Farooq 7, Wade Lee Smith 8, Joyce Badal 9, Anas Renno 10, Toseef Javaid 11, Ali Nawras 12, Sammy Saab 13
|
|
| |
|
|
| |
| 9. | Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding |
| |
Gut. 2023 Apr;72(4):749-758. doi: 10.1136/gutjnl-2022-326975.Epub 2022 Sep 9.
Marika Rudler 1 2 3, Virginia Hernández-Gea 4, Bogdan Dumitru Procopet 5 6, Alvaro Giráldez 7, Lucio Amitrano 8, Càndid Villanueva 9 10, Luis Ibañez 11 12, Gilberto Silva-Junior 4, Joan Genesca 13, Christophe Bureau 14, Jonel Trebicka 15, Rafael Bañares 16, Aleksander Krag 17, Elba Llop 18, Wim Laleman 19, Jose Maria Palazon 20, Jose Castellote 21, Susana Rodrigues 22, Lise Lotte Gluud 23, Carlos Noronha Ferreira 24, Nouria Canete 25, Manuel Rodríguez 26, Arnulf Ferlitsch 27, Jose Luis Mundi 28, Henning Gronbaek 29, Manuel Hernandez-Guerra 30, Romano Sassatelli 31, Alessandra Dell'era 32 33, Marco Senzolo 34, Juan G Abraldes 35, Manuel Romero-Gómez 36, Alexander Zipprich 37, Meritxell Casas 38, Helena Masnou 39, Hélène Larrue 40, Massimo Primignani 41, Frederik Nevens 42, Jose Luis Calleja 43 44, Remy Schwarzer 27, Christian Jansen 45, Marie-Angèle Robic 40, Irene Conejo 46, Javier Martínez Gonzalez 47, Maria Vega Catalina 48, Agustín Albillos 49 50, Edilmar Alvarado 51, Maria Anna Guardascione 52, Maxime Mallet 53, Simona Tripon 53, Georgina Casanovas 54, Jaume Bosch 55, Juan-Carlos Garcia-Pagan 4, Dominique Thabut 53 2 3; for International Variceal Bleeding Observational Study Group: a Baveno Cooperation
|
|
| |
|
|
| |
| 11. | Hepatic encephalophaty: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3) |
| |
Minerva Med. 2023 Mar 23. doi: 10.23736/S0026-4806.22.08408-7. Online ahead of print.
Gianni Testino 1, Luigi C Bottaro 2, Enzo Andorno 3, Fabio Bandini 4, Patrizia Balbinot 5, Sabrina Beltramini 6, Simona Bottino 7, Marta Caltabellotta 8, Fabio Caputo 9 10 11 12, Enrica Caviglia 13, Pierfrancesco Curone 14, Antonio DI Biagio 15, Carmelo Gagliano 16, Nicoletta Gandolfo 14, Luca Pestarino 17, Alessandro Rollero 18, Emanuele Romairone 19, Lorenzo Sampietro 20, Enrico Torre 21, Silvia Zuccarelli 22, Rinaldo Pellicano 23
|
|
| |
|
|
| |
| 13. | Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival |
| |
Transplantation. 2023 Feb 1;107(2):410-419. doi: 10.1097/TP.0000000000004303.Epub 2023 Jan 26.
Ilias Kounis 1 2 3 4, Mylène Sebagh 2 3 4 5, Manon Evain 1, Valérie Cailliez 1 2 3 4, Bruno Roche 1 2 3 4, Eleonora De Martin 1 2 3 4, Rodolphe Sobesky 1 2 3 4, Catherine Guettier 2 3 4 5, Marc Antoine Allard 1 2 3 4, Nicolas Golse 1 2 3 4, Daniel Azoulay 1 2 3 4, Eric Vibert 1 2 3 4, Jean Charles Duclos Vallee 1 2 3 4, Cyrille Feray 1 2 3 4, Didier Samuel 1 2 3 4, Audrey Coilly 1 2 3 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 21. | A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study |
| |
Hepatol. 2023 Feb;78(2):312-321.doi: 10.1016/j.jhep.2022.09.009. Epub 2022 Sep 22.
Andrew Fagan 1, Edith A Gavis 1, Mary Leslie Gallagher 1, Travis Mousel 1, Brian Davis 1, Puneet Puri 1, Richard K Sterling 1, Velimir A Luketic 1, Hannah Lee 1, Scott C Matherly 1, Arun J Sanyal 1, R Todd Stravitz 1, Vaishali Patel 1, Mohammad S Siddiqui 1, Amon Asgharpour 1, Michael Fuchs 1, Leroy Thacker 2, Jasmohan S Bajaj 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 31. | Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers |
| |
Hepatol Commun. 2023 Jan 27;7(2):e0030.doi: 10.1097/HC9.0000000000000030. eCollection 2023 Feb 1.
Jawaid Shaw 1, Chathur Acharya 2, Somaya Albhaisi 1, Andrew Fagan 3, Sara McGeorge 2, Melanie B White 2, Jatinder Lachar 1, Jessica Olson 4, Amy Olofson 4, Lori Bergstrom 4, Patrick S Kamath 4, Jasmohan S Bajaj 2 3
|
|
| |
| 32. | Diagnosis and management of hepatic encephalopathy: The French recommendations |
| |
Liver Int. 2023 Jan 10. doi: 10.1111/liv.15510. Online ahead of print.
Dominique Thabut 1, Charlotte Bouzbib 1, Lucy Meunier 2, Manon Haas 3, Nicolas Weiss 4, Alexandre Louvet 5, Francois Imbert-Bismut 6, Fanny Mochel 7, Yann Nadjar 8, Antoine Santiago 1, Thierry Thevenot 9, Véronique Duhalde 10, Frédéric Oberti 11, Claire Francoz 12, Audrey Coilly 3, Marie-Noelle Hilleret 13, Pascal Lebray 1, Amélie Liou-Schischmanoff 14, Louise Barbier 15, Christophe Duvoux 16, Georges-Philippe Pageaux 2, Michael Bismuth 17, Damien Galanaud 18, Thomas De Broucker 19, Jean-François Cadranel 20, Vincent Leroy 16, Vincent Di Martino 9, Dominique Larrey 2, Christophe Camus 21, Olivier Scatton 22, Victor De Ledinghen 23, Ariane Mallat 16, Marika Rudler 1, Christophe Bureau 24; Association Française pour l'Etude du Foie (AFEF) group of experts of HE recommendations
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 36. | Transjugular Intrahepatic Portosystemic Shunt Outcomes in the Elderly Population: A Systematic Review and Meta-Analysis |
| |
Gastroenterology Res. 2022 Dec;15(6):325-333. doi: 10.14740/gr1571. Epub 2022 Dec 1.
Zohaib Ahmed 1, Umer Farooq 2, Syeda Faiza Arif 3, Muhammad Aziz 4, Umair Iqbal 5, Ahmad Nawaz 6, Wade Lee-Smith 7, Joyce Badal 8, Asif Mahmood 1, Abdallah Kobeissy 4, Ali Nawras 4, Mona Hassan 4, Sammy Saab 9
|
|
| |
| 37. | Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know |
| |
Abdom Radiol (NY). 2022 Dec;47(12):4254-4270.doi: 10.1007/s00261-022-03685-0. Epub 2022 Sep 19.
Giuseppe Mamone 1, Mariapina Milazzo 2, Ambra Di Piazza 2, Settimo Caruso 2, Vincenzo Carollo 2, Giovanni Gentile 2, Francesca Crinò 2, Gianluca Marrone 2, Gianvincenzo Sparacia 2, Luigi Maruzzelli 2, Roberto Miraglia 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 45. | Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosis |
| |
Gut. 2022 Nov 7;gutjnl-2022-328403. doi: 10.1136/gutjnl-2022-328403. Online ahead of print.
Jasmohan S Bajaj 1 2, Marcela Peña-Rodriguez 3, Alex La Reau 4, Wendy Phillips 4, Michael Fuchs 5 2, Brian C Davis 5 2, Richard K Sterling 5 2, Masoumeh Sikaroodi 6, Andrew Fagan 2, Amirhossein Shamsaddini 6, Zachariah Henseler 4, Tonya Ward 4, Puneet Puri 5 2, Hannah Lee 5 2, Patrick M Gillevet 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 51. | Minimal hepatic encephalopathy is associated to alterations in eye movements |
| |
Sci Rep. 2022 Oct 7;12(1):16837. doi: 10.1038/s41598-022-21230-3.
Franc Casanova-Ferrer # 1, Cecilia E García-Cena # 2, Juan-Jose Gallego 1, Alessandra Fiorillo 1, Amparo Urios 1, Alberto Calvo-Córdoba 2, Maria-Pilar Ballester 1 3, María Pilar Ríos 4, Lucía Durbán 4, Marta R Hidalgo 5, Francisco García 5, Vicente Felipo 6, Carmina Montoliu 7 8
|
|
| |
| 52. | Role Of Oral Health, Frailty and Minimal Hepatic Encephalopathy In The Risk Of Hospitalization: A Prospective Multi-Center Cohort Of Outpatients with Cirrhosis |
| |
Clin Gastroenterol Hepatol. 2022 Oct 31;S1542-3565(22)01012-6.doi: 10.1016/j.cgh.2022.10.023. Online ahead of print.
Jasmohan S Bajaj 1, Jennifer C Lai 2, Puneeta Tandon 3, Jacqueline G O'Leary 4, Florence Wong 5, Guadalupe Garcia-Tsao 6, Hugo E Vargas 7, Patrick S Kamath 8, Scott W Biggins 9, Ana Limon-Moro 4, Jawaid Shaw 10, Chimezie Mbachi 6, Michael Chew 6, Janina Golob Deeb 11, Leroy R Thacker 12, K Rajender Reddy 13
|
|
| |
|
|
| |
|
|
| |
| 55. | Brain magnetic resonance imaging radiomics features associated with hepatic encephalopathy in adult cirrhotic patients |
| |
Neuroradiology. 2022 Oct;64(10):1969-1978. doi: 10.1007/s00234-022-02949-2.Epub 2022 Apr 30.
Gianvincenzo Sparacia 1 2, Giuseppe Parla 3, Roberto Cannella 4, Giuseppe Mamone 3, Ioannis Petridis 5, Luigi Maruzzelli 3, Vincenzina Lo Re 6, Mona Shahriari 7, Alberto Iaia 7, Albert Comelli 8, Roberto Miraglia 3, Angelo Luca 3
|
|
| |
|
|
| |
| 57. | North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension |
| |
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36.doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.
Justin R Boike 1, Bartley G Thornburg 2, Sumeet K Asrani 3, Michael B Fallon 4, Brett E Fortune 5, Manhal J Izzy 6, Elizabeth C Verna 7, Juan G Abraldes 8, Andrew S Allegretti 9, Jasmohan S Bajaj 10, Scott W Biggins 11, Michael D Darcy 12, Maryjane A Farr 13, Khashayar Farsad 14, Guadalupe Garcia-Tsao 15, Shelley A Hall 16, Caroline C Jadlowiec 17, Michael J Krowka 18, Jeanne Laberge 19, Edward W Lee 20, David C Mulligan 21, Mitra K Nadim 22, Patrick G Northup 23, Riad Salem 2, Joseph J Shatzel 24, Cathryn J Shaw 25, Douglas A Simonetto 26, Jonathan Susman 27, K Pallav Kolli 19, Lisa B VanWagner 28, Advancing Liver Therapeutic Approaches (ALTA) Consortium
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 64. | Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation |
| |
Am J Gastroenterol. 2022 Jul 11. doi: 10.14309/ajg.0000000000001901. Online ahead of print.
Ethan M Weinberg 1, Matthew Dukewich 2, Neha Jakhete 3, Elizabeth Stonesifer 3, Gene Y Im 4, Michael R Lucey 5, Kirti Shetty 3, John P Rice 5, David W Victor 3rd 6, Mark R Ghobrial 6, Akshay Shetty 6, Stephanie M Rutledge 7, Sander S Florman 4, Christine Hsu 8, Mohamed Shoreibah 9, Mahmoud Aryan 10, Babak J Orandi 11, Hyosun Han 12, Norah Terrault 12, Brian P Lee 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 73. | Hepatic encephalopathy |
| |
Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6.
Dieter Häussinger 1, Radha K Dhiman 2, Vicente Felipo 3, Boris Görg 4, Rajiv Jalan 5 6, Gerald Kircheis 7, Manuela Merli 8, Sara Montagnese 9, Manuel Romero-Gomez 10, Alfons Schnitzler 11, Simon D Taylor-Robinson 12, Hendrik Vilstrup 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 81. | Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort |
| |
Clin Gastroenterol Hepatol. 2022 Apr 15;S1542-3565(22)00388-3.doi: 10.1016/j.cgh.2022.03.046. Online ahead of print.
Jasmohan S Bajaj 1, Puneeta Tandon 2, Jacqueline G O'Leary 3, K Rajender Reddy 4, Guadalupe Garcia-Tsao 5, Paul Thuluvath 6, Jennifer C Lai 7, Ram M Subramanian 8, Hugo E Vargas 9, Florence Wong 10, Andrew Fagan 11, Sara McGeorge 11, Leroy R Thacker 11, Patrick S Kamath 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 86. | Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis |
| |
Hepatol Commun. 2022 May;6(5):1113-1122. doi: 10.1002/hep4.1883. Epub 2022 Jan 14.
Simon Johannes Gairing 1 2, Julian Anders 1, Leonard Kaps 1 2, Michael Nagel 1 2, Maurice Michel 1 2, Wolfgang Maximilian Kremer 1 2, Max Hilscher 1 2, Peter Robert Galle 1 2, Jörn M Schattenberg 1 3, Marcus-Alexander Wörns 1 2 4, Christian Labenz 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 94. | Rifaximin-a reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial |
| |
J Hepatol. 2022 Feb;76(2):332-342.doi: 10.1016/j.jhep.2021.09.010. Epub 2021 Sep 24.
Vishal C Patel 1, Sunjae Lee 2, Mark J W McPhail 3, Kevin Da Silva 4, Susie Guilly 4, Ane Zamalloa 5, Elizabeth Witherden 6, Sidsel Støy 7, Godhev Kumar Manakkat Vijay 8, Nicolas Pons 4, Nathalie Galleron 4, Xaiohong Huang 8, Selin Gencer 9, Muireann Coen 9, Thomas Henry Tranah 10, Julia Alexis Wendon 10, Kenneth D Bruce 11, Emmanuelle Le Chatelier 4, Stanislav Dusko Ehrlich 4, Lindsey Ann Edwards 8, Saeed Shoaie 12, Debbie Lindsay Shawcross 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 119. | The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial |
| |
Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-0202. Online ahead of print.
Christophe Bureau 1, Dominique Thabut 2, Caroline Jezequel 3, Isabelle Archambeaud 4, Louis D'Alteroche 5, Sêbastien Dharancy 6, Patrick Borentain 7, Frédéric Oberti 8, Aurélie Plessier 9, Victor De Ledinghen 10, Nathalie Ganne-Carrié 11, Nicolas Carbonell 12, Vanessa Rousseau 13, Agnès Sommet 13, Jean Marie Péron 1, Jean Pierre Vinel 1
|
|
| |
|
|
| |
|
|
| |
| 122. | North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension |
| |
Clin Gastroenterol Hepatol. 2021 Jul 15;S1542-3565(21)00749-7.doi: 10.1016/j.cgh.2021.07.018. Online ahead of print.
Justin R Boike 1, Bartley G Thornburg 2, Sumeet K Asrani 3, Michael B Fallon 4, Brett E Fortune 5, Manhal J Izzy 6, Elizabeth C Verna 7, Juan G Abraldes 8, Andrew S Allegretti 9, Jasmohan S Bajaj 10, Scott W Biggins 11, Michael D Darcy 12, Maryjane A Farr 13, Khashayar Farsad 14, Guadalupe Garcia-Tsao 15, Shelley A Hall 16, Caroline C Jadlowiec 17, Michael J Krowka 18, Jeanne Laberge 19, Edward W Lee 20, David C Mulligan 21, Mitra K Nadim 22, Patrick G Northup 23, Riad Salem 2, Joseph J Shatzel 24, Cathryn J Shaw 25, Douglas A Simonetto 26, Jonathan Susman 27, K Pallav Kolli 19, Lisa B VanWagner 28, Advancing Liver Therapeutic Approaches (ALTA) Consortium
|
|
| |
|
|
| |
| 124. | Sleep and liver disease: a bidirectional relationship |
| |
Lancet Gastroenterol Hepatol. 2021 Jul 14;S2468-1253(21)00169-2.doi: 10.1016/S2468-1253(21)00169-2. Online ahead of print.
Thomas Marjot 1, David W Ray 2, Felicity R Williams 3, Jeremy W Tomlinson 2, Matthew J Armstrong 4
|
|
| |
|
|
| |
|
|
| |
| 127. | Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) |
| |
BMJ Open Gastroenterol. 2020 Dec;7(1):e000531. doi: 10.1136/bmjgast-2020-000531.
K de Wit 1, J J Schaapman 2, F Nevens 3, J Verbeek 3, S Coenen 4, F J C Cuperus 5, M Kramer 6, E T T L Tjwa 7, N Mostafavi 8, M G W Dijkgraaf 9, O M van Delden 10, U H W Beuers 1, M J Coenraad 2, R B Takkenberg 11
|
|
| |
| 128. | The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis |
| |
J Hepatol. 2020 Dec 7;S0168-8278(20)33836-8. doi: 10.1016/j.jhep.2020.11.048.Online ahead of print.
Vicente Arroyo 1, Paolo Angeli 2, Richard Moreau 3, Rajiv Jalan 4, Joan Claria 5, Jonel Trebicka 6, Javier Fernández 5, Thierry Gustot 7, Paolo Caraceni 8, Mauro Bernardi 8, investigators from the EASL-CLIF Consortium, Grifols Chair; European Foundation for the Study of Chronic Liver Failure (EFClif)
|
|
| |
|
|
| |
| 130. | The use of Rifaximin in Patients with Cirrhosis |
| |
Hepatology. 2021 Jan 9. doi: 10.1002/hep.31708. Online ahead of print.
Paolo Caraceni 1, Victor Vargas 2, Elsa Solà 3, Carlo Alessandria 4, Koos de Wit 5, Jonel Trebicka 6 7, Paolo Angeli 8, Rajeshwar P Mookerjee 9, François Durand 10, Elisa Pose 3, Aleksander Krag 11 12, Jasmohan S Bajaj 13, Ulrich Beuers 5, Pere Ginès 3
|
|
| |
|
|
| |
|
| |
|
|
|
|
|
Stay Informed!
